Richard P. Junghans
Richard P. Junghans
Associate Professor of Medicine
Education:
MD, University of Miami
PhD, University of California, Berkley
General field of research:
Immunology; Oncology; Gene Therapy
Affiliations other than medicine:
Evans Center for Interdisciplinary Biomedical Research
Roger Williams Medical Center Director, Biotherapeutics Development Lab
Contact information:
Office
825 Chalkstone Avenue Providence, RI 02908
Keywords:
T cells Immunotherapy; Gene Therapy
Summary of research interest:
Richard P. Junghans, Ph.D., M.D., Associate Professor of Medicine, Boston University School of Medicine, is Director, Biotherapeutics Development Lab (BDL). Dr. Junghans brings dual backgrounds in basic science and clinical medicine to a research program in clinical translational research. He obtained his MD (U Miami) and training in Internal Medicine (Georgetown) and Hematology-Oncology (NCI/NIH), where he trained in immunology with Dr Thomas Waldmann, and his Ph.D. in Molecular Biology (UC Berkeley) in which his thesis described activities of retrovirus reverse transcriptases.
He applies molecular engineering techniques to develop new immunotherapies to treat cancer and infectious diseases, and is a rec0gnized leader in the field of cancer gene therapy. He has completed Institutional Review Board applications, initiated Phase I and Phase II human clinical trials, secured FDA Investigational New Drug (IND) status for antibody and gene therapy agents and previously established an on-campus facility for gene therapy applications. Dr. Junghans has more than 70 publications. He is Board Certified in Internal Medicine and Medical Oncology and Board Eligible in Hematology.
